121
|
|
|
EP300 interacting inhibitor of differentiation 2B |
EID-2B, EID-3 |
|
122
|
|
|
Eukaryotic translation initiation factor 1 |
A121, EIF-1, EIF1A, ISO1, SUI1 |
|
123
|
|
|
Eukaryotic translation initiation factor 1A domain containing |
OBELIX, haponin |
|
124
|
|
|
Eukaryotic translation initiation factor 1A X-linked |
EIF1A, EIF1AP1, EIF4C, eIF-1A, eIF-4C |
|
125
|
|
|
Eukaryotic translation initiation factor 1A Y-linked |
eIF-4C |
|
126
|
|
|
Eukaryotic translation initiation factor 2A |
CDA02, EIF-2A, MST089, MSTP004, MSTP089 |
|
127
|
|
|
Eukaryotic translation initiation factor 2 alpha kinase 1 |
HCR, HRI, LEMSPAD, hHRI |
|
128
|
|
|
Eukaryotic translation initiation factor 2 alpha kinase 2 |
DYT33, EIF2AK1, LEUDEN, PKR, PPP1R83, PRKR |
Alzheimer disease, Developmental regression, Dystonia, Torsion dystonia, Early-onset generalized limb-onset dystonia, Global developmental delay, Gout, Hepatitis b, Huntington disease, Parkinson disease, Prostatic neoplasms, Scoliosis, Status epilepticus |
129
|
|
|
Eukaryotic translation initiation factor 2 alpha kinase 3 |
PEK, PERK, WRS |
Breast cancer, Connective tissue disease, Desbuquois syndrome, Diabetes mellitus type 1, Epiphyseal dysplasia, Myocardial ischemia, Progressive supranuclear palsy, Sialolithiasis, Status epilepticus, Uterine fibroid, Wolcott-rallison syndrome |
130
|
|
|
Eukaryotic translation initiation factor 2 alpha kinase 4 |
GCN2, PVOD2 |
|